Related Content
December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard ...
December 31, 2008
December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the ...
December 28, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now